Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Abbott Acquires Kos Pharmaceuticals | Contract Pharma

What are you searching for?

Sign in
Breaking News

Abbott Acquires Kos Pharmaceuticals

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Abbott has acquired a majority of the shares of Kos Pharmaceuticals, Inc. for $3.7 billion. The acquisition follows a scheduled expiration on December 12th for the purchase of all outstanding common stock of Kos. Abbott’s shares now represent approximately 91.4% of Kos’ outstanding shares.

The merger is expected to occur within the next few days.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters